Pseudohypoparathyroidism and Growth

  • S. Semiz
  • F. Duzcan


Pseudohypoparathyroidism (PHP) is a disorder characterized by hypocalcemia and hyperphosphatemia due to resistance to parathyroid hormone (PTH). There are two main subtypes of PHP, named as PHP types Ia and Ib and caused by genetic alterations within upstream of the GNAS locus. Heterozygous inactivating mutations within alpha subunit of the stimulatory G protein (G) encoding GNAS exons are found in patients with PHP-Ia. These patients often present with additional hormonal resistance and show characteristic physical features that are totally called as Albright’s hereditary osteodystrophy (AHO). AHO is characterized by short stature, brachydactyly, obesity, skull facial deformities (round face, short neck, flat wide nose, and teeth hypoplasia), short limbs due to brachydactyly or short metacarpal bones, subcutaneous calsinosis, and, in some cases, mental or developmental abnormalities. These features are also present in pseudopseudohypoparathyroidism (PPHP); however, patients affected by this disorder show the same features except hormone resistance. Maternal inheritance of a mutation leads to PHP-Ia with AHO plus hormone resistance, while paternal inheritance of the same mutation leads to PPHP with AHO only. PHP-Ib patients present predominantly with renal PTH resistance and do not show any features of AHO. The proposed mechanism of both the familial autosomal dominant form of PHP-Ib and the sporadic form of PHP-Ib is the distribution of long-range imprinting control elements of GNAS locus, with consequent decreased G transcription in the proximal renal tubules and PTH resistance. It is widely known that patients with PHP-Ia and PPHP have short stature. The effects of G -inactivating mutations on skeletal growth are likely to involve a number of factors. One effect will be intrinsic to the growth plate, because G couples to PTH/PTH-related polypeptide (PTHrP) receptor to adenylate cyclase and cyclic adenosine monophosphate production, controlling the proliferation and differentiation of chondrocytes. Another explanation is that many patients with PHP-Ia have insufficient growth hormone (GH) and exhibit a partial resistance to growth hormone-releasing hormone (GHRH). This condition could have an additive effect on the growth defects, which are mediated by blunted signaling from the PTH/PTHrP receptor owing to G deficiency. In contrast with what is observed in PHP-Ia, patients with PHP-Ib display normal responsiveness to GHRH and normal IGF-I levels. These data provide new information on this rare disease and emphasize the clinical heterogeneity of genetic defects within the GNAS locus.


Growth Hormone Growth Plate Growth Hormone Deficiency Adult Height Hormone Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Autosomal dominant pseudohypoparathyroidism type 1b


Albright’s hereditary osteodystrophy




cyclic Adenosine monophosphate


Differentially methylated region


Growth hormone


Growth hormone-releasing hormone


Alpha subunit of the stimulatory G protein (G)


Neuroendocrine secretory protein






Pseudohypoparathyroidism type 1a




Parathyroid hormone


PTH/PTH-related polypeptide


Thyroid stimulating hormone


Extra-large variant of Gsα


  1. Ahrens W, Hiort O. Determination of Gs alpha protein activity in Albright’s hereditary osteodystrophy. J Pediatr Endocrinol Metab. 2006;19:647–55.PubMedCrossRefGoogle Scholar
  2. Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism – an example of ‘Seabright-Bantam syndrome’. Endocrinology. 1942;30:922–32.Google Scholar
  3. Bastepe M. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol. 2008;626:27–40.PubMedCrossRefGoogle Scholar
  4. Bastepe M, Juppner H. Pseudohypoparathyroidism and mechanisms of resistance toward multipl hormones: molecular evidence to clinical presentation. J Clin Endocrinol Metab. 2003;88:4055–8.PubMedCrossRefGoogle Scholar
  5. Bastepe M, Lane AH, Jüppner H. Paternal uniparentalisodisomy of chromosome 20q (patUPD20q)– and the resulting changes in GNAS1 methylation – as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet. 2001a;68:1283–9.Google Scholar
  6. Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Jüppner H. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet. 2001b;10:1231–41.PubMedCrossRefGoogle Scholar
  7. De Sanctis L, Romaglono D, Olivero M, Buzi F, Maghnie M, Scire G, Crino A, Baroncelli GI, Salerno M, Di Maio S, Cappa M, Grosso S, Rigon F, Lala R, De Sanctis C, Dianzani I. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatric Res. 2003;53:749–55.CrossRefGoogle Scholar
  8. De Sanctis L, Bellone J, Salerno M, Faleschini E, Caruso-Nicoletti M, Cicchetti M, Concolino D, Balsamo A, Buzi F, Ghizzoni L, de Sanctis C. GH secretion in a cohort of children with pseudohypoparathyroidism type Ia. J Endocrinol Invest. 2007;30:97–103.PubMedGoogle Scholar
  9. De Nanclares GP, Fernández-Rebollo E, Santin I, García-Cuartero B, Gaztambide S, Menéndez E, Morales MJ, Pombo M, Bilbao JR, Barros F, Zazo N, Ahrens W, Jüppner H, Hiort O, Castaño L, Bastepe M. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright’s hereditary osteodystrophy. J Clin Endocrinol Metab. 2007;92:2370–3.PubMedCrossRefGoogle Scholar
  10. Drezner M, Neelon FA, Lebovitz HE. Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med. 1973;289:1056–60.PubMedCrossRefGoogle Scholar
  11. Farfel Z, Bourne HB, Iiri T. The expending spectrum of G protein disease. N Engl J Med. 1999;340:1012.PubMedCrossRefGoogle Scholar
  12. Faull CM, Welbury RR, Paul B, Kendall-Taylor PQ. Pseudohypoparathyroidism: its phenotypicvariability and associated disorders in a in a large family. J Med. 1991;78:251–64.Google Scholar
  13. Germain-Lee EL, Ding CL, Deng Z, Crane JL. Paternal imprinting of Gsα in the human thyroid. Biochem Biopysh Res Comm. 2002;8:67–72.CrossRefGoogle Scholar
  14. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab. 2003;88:4059–69.Google Scholar
  15. Germain-Lee EL, Schwindinger W, Crane JL, Zewdu R, Zweifel LS, Wand G, Huso DL, Saji M, Ringel MD, Levine MA. A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology. 2005;146:4697–709.PubMedCrossRefGoogle Scholar
  16. Hayward BE, Barlier A, Korbonits M, Grossman AB, Jacquet P, Enjalbert A, Bonthron DT. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest. 2001;107:31–6.CrossRefGoogle Scholar
  17. Jüppner H, Schipani E, Bastepe M, Cole DEC, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA. 1998;95:11798–803.PubMedCrossRefGoogle Scholar
  18. Kelsey G. Epigenetics and imprinted genes: insights from the imprinted Gnas locus. Horm Res Suppl. 2009;2:22–9.CrossRefGoogle Scholar
  19. Kinoshita K, Minagawa M, Anzai M, SatoY, Kazukawa I, Shimohashi K, Ota S, Kohno Y. Characteristic height growth pattern in patients with pseudohypoparathyroidism. Clin Pediatr Endocrinol. 2007;1:31–6.CrossRefGoogle Scholar
  20. Levine MA. Pseudohypoparathyroidism. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. New York, NY: Academic; 2002. pp. 1137–63.CrossRefGoogle Scholar
  21. Liu J, Erlichman B, Weinstein LS. The stimulatory G protein α-subunit Gsα is imprinted inhuman thyroid glands: implications for thyroidfunction in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metabol. 2003;88:4336–41.CrossRefGoogle Scholar
  22. Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras Endocrinol Metabol. 2006;50:664–73.PubMedCrossRefGoogle Scholar
  23. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs gene. J Clin Endocrinol Metab. 2003;88:4070–4.PubMedCrossRefGoogle Scholar
  24. Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A. Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J Clin Endocrinol Metab. 2004;89:6316–9.PubMedCrossRefGoogle Scholar
  25. Mantovani G, Bondioni S, Linglart A, Maghnie M, Cisternino M, Corbetta S, Lania AG, Beck-Peccoz P, Spada A. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab. 2007;92:3738–42.PubMedCrossRefGoogle Scholar
  26. Online Mendelian Inheritance in Man, OMIM(TM). Baltimore, MD. Johns Hopkins University, MIM Number: {103580}:{5/18/2009}. World Wide Web URL:
  27. Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Weinstein LS. Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J Bone Miner Res. 2005;20:663–71.PubMedCrossRefGoogle Scholar
  28. Silve C, Santora A, Breslau N, Moses A, Spiegel A. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab. 1986;62:640–4.PubMedCrossRefGoogle Scholar
  29. Thiele S, Werner R, Ahrens W, Hoppe U, Marschke C, Staedt P, Hiort O. A disruptive mutation in exon 3 of the GNAS gene with Albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gs{alpha}-L deficiency. J Clin Endocrinol Metab. 2007;92:2370–3.CrossRefGoogle Scholar
  30. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein subunit mutations and the role of genomic imprinting. Endocr Rev. 2001;22:675–705.PubMedCrossRefGoogle Scholar
  31. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology. 2004;145:5459–64.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Pediatric Endocrinology, Department of PediatricsSchool of Medicine, Pamukkale UniversityDenizliTurkey
  2. 2.Department of Medical GeneticsSchool of Medicine, Pamukkale UniversityDenizliTurkey

Personalised recommendations